FDA.reportPublic FDA data

NDC 71266-8515-1

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC
71266-8515-1
Product root
71266-8515
Identity scope
Package
Primary current NDC product row
Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
compounderpackage71266-851571266-8515-1COMPOUNDEROutsourcing facility compounded drug report2021-12026-08-08
compounderpackage71266-851571266-8515-1COMPOUNDEROutsourcing facility compounded drug report2020-22026-08-08
compounderpackage71266-851571266-8515-1COMPOUNDEROutsourcing facility compounded drug report2020-12026-08-08
compounderpackage71266-851571266-8515-1COMPOUNDEROutsourcing facility compounded drug report2019-22026-08-08
compounderpackage71266-851571266-8515-1COMPOUNDEROutsourcing facility compounded drug report2019-12026-08-08

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 5 matching rows.

View current auxiliary records. · View the auxiliary file history.

Reporting period table
Reporting period
2021-1
2020-2
2020-1
2019-2
2019-1

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
EstablishmentFEIProduct NDCPackage NDCProductActive ingredientsReporting periodNormalization
JCB Laboratories LLC17716747071266-851571266-8515-1Mitomycin.4 mg/1 mL2021-1valid
JCB Laboratories LLC17716747071266-851571266-8515-1Mitomycin.4 mg/1 mL2020-2valid
JCB Laboratories LLC17716747071266-851571266-8515-1Mitomycin.4 mg/1 mL2020-1valid
JCB Laboratories LLC17716747071266-851571266-8515-1Mitomycin.4 mg/1 mL2019-2valid
JCB Laboratories LLC17716747071266-851571266-8515-1Mitomycin.4 mg/1 mL2019-1valid
Fagron Compounding Services LLC dba Fagron Sterile Services LLC07997724971266-851571266-8515-3Mitomycin.4 mg/1 mL2025-2valid
Fagron Compounding Services LLC dba Fagron Sterile Services LLC07997724971266-851571266-8515-3Mitomycin.4 mg/1 mL2025-1valid
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories71266-851571266-8515-3Mitomycin 0.4mg/mL.4 mg/1 mL2025-1valid
Fagron Compounding Services LLC dba Fagron Sterile Services LLC07997724971266-851571266-8515-3Mitomycin.4 mg/1 mL2024-2valid
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories71266-851571266-8515-3Mitomycin 0.4mg/mL.4 mg/1 mL2024-2valid
Fagron Compounding Services LLC dba Fagron Sterile Services LLC07997724971266-851571266-8515-3Mitomycin.4 mg/1 mL2024-1valid
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories71266-851571266-8515-3Mitomycin 0.4mg/mL.4 mg/1 mL2024-1valid
Fagron Compounding Services LLC dba Fagron Sterile Services LLC07997724971266-851571266-8515-3Mitomycin.4 mg/1 mL2023-2valid
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories71266-851571266-8515-3Mitomycin 0.4mg/mL.4 mg/1 mL2023-2valid
Fagron Compounding Services LLC dba Fagron Sterile Services LLC07997724971266-851571266-8515-3Mitomycin.4 mg/1 mL2023-1valid
Fagron Compounding Services LLC dba Fagron Sterile Services LLC07997724971266-851571266-8515-3Mitomycin.4 mg/1 mL2022-2valid